
Nvidia CEO dismisses Trump tariff concerns: ‘We'll work through it'
'Nobody likes disruptions and no one likes abrupt changes, but these settlements will — President Trump will settle these deals and countries will reorganize and resettle, and we'll work through it,' Huang said in an interview with USA Today published on Friday.
Trump has reshuffled U.S. trade policy since returning to the White House, and he has recently notified countries about the tariff rates some will face at the start of next month. The president has alerted nations about the 'reciprocal' rate that will come into effect on Aug. 1, and some of warned of countermeasures and called for further negotiations.
'Every single year there were rules and taxes and tariffs and policies and regulations, and we survived. I have every confidence that the world is going to survive this, companies will survive this and whatever it turns out to be, we'll make the best of it,' Huang said.
This week, Nvidia became the first public-traded company to hit a market capitalization above $4 trillion. Huang met with Trump at the White House the same day. The two have had five meetings since the president took office on Jan. 20, USA Today reported.
Huang said on Friday that the U.S. has to manufacture more semiconductors, arguing the push will yield benefits across various sectors.
'Absolutely. I believe President Trump's vision, his bold vision to manufacture in the United States, it's great for our industries, it's great for our society,' the Nvidia head said to USA TODAY.
'We've lost a lot of manufacturing capability and skills, which is really great for skilled craft and people that work with their hands and build things,' he added. 'We want to celebrate that. We want to bring that back to the United States. It's very important to national security, industrial security, supply chain resilience.'
His remarks come as a bipartisan duo, Sens. Elizabeth Warren (D-Mass.) and Jim Banks (R-Ind.), sent a letter to Huang this week, asking him to reconsider an upcoming visit to China over national security concerns.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Gitlab (GTLB) Falls 9.3% on Critical Security Concerns
GitLab Inc. (NASDAQ:GTLB) is one of the GitLab saw its share price drop by 9.3 percent week-on-week, as investor sentiment turned cautious following the release of several critical patches to address vulnerabilities. In a statement posted on its website last week, GitLab said the most critical flaw carries a CVSS (Common Vulnerability Scoring System) score of 8.7, considered highly severe, as it could allow hackers to execute malicious actions on behalf of its users through content injection. Another one, rated medium, could allow restriction bypass through API manipulation. Two others with low severity scores were also addressed, which could allow authenticated users to bypass various group-level restrictions through crafted API requests or manipulation of group invitation functionality. GitLab Inc. (NASDAQ:GTLB) urged all its users to immediately upgrade all self-managed installations to the latest security patches. A team of software engineers working together in an open office, developing innovative solutions. In other news, GitLab Inc. (NASDAQ:GTLB) remained a stock 'buy' for BofA Securities, giving the company a whopping price target of $72, marking a 71.3-percent upside from its last closing price of $42.03. BofA Securities said it was optimistic about the company's duo strategy, which it expected to drive higher adoption of premium paid tiers and add-on AI products such as Duo Pro, Duo Enterprise, and the Agent Platform. While we acknowledge the potential of GTLB as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
19 minutes ago
- Yahoo
Ultragenyx (RARE) Falls 26% as New Treatment Fails to Get FDA Green Light
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the Ultragenyx fell by 26.05 percent week-on-week as investor sentiment was largely dragged down by the Food and Drug Administration's (FDA) rejection of its biologics license application (BLA) for its UX111 (ABO-102) treatment. In a regulatory filing, Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) said that the FDA requested additional information and improvements in relation to certain chemistry, manufacturing, and controls (CMC) aspects. It noted that the observations were not related to product quality concerns product, adding that many of the issues have already been addressed. UX111 was developed to treat a common type of Sanfilippo syndrome, a group of genetic conditions that begin in early childhood and causes severe brain damage and early death. A research team in a laboratory peering through microscopes at a biologic product. The treatment involves managing symptoms, as there are currently no approved disease-modifying medicines. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) said it plans to resubmit updated clinical data from current patients after resolving the FDA's concerns. A new review could take another six months upon resubmission of a revised BLA application. While we acknowledge the potential of RARE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.


Miami Herald
24 minutes ago
- Miami Herald
Trump Gets ‘Ratioed' on Truth Social for First Time Amid Epstein Backlash
President Donald Trump's weekend post defending Attorney General Pam Bondi's handling of the Jeffrey Epstein files has triggered an unprecedented backlash, marking the first time the Republican has been "ratioed" on his own social media platform, Truth Social. The term "ratioed" refers to when a social media post receives more replies than likes or shares, often signaling more disagreement or criticism than support. In his Saturday evening post, Trump lashed out at those criticizing Bondi, calling her performance "FANTASTIC" and dismissing the ongoing interest in Epstein as a waste of time. "We're on one Team, MAGA, and I don't like what's happening," the president wrote. "Let's not waste Time and Energy on Jeffrey Epstein, somebody that nobody cares about." The post—lengthy, defensive, and directed at his own base—appears to have backfired. According to public engagement data archived from Truth Social, the post has garnered more than 36,000 replies, compared with nearly 11,000 re-truths (the platform's term for shares) and 32,000 likes as of 10:45 a.m. ET Sunday. The backlash on Truth Social reflects growing internal division among MAGA supporters, many of whom have spent months anticipating revelations from the so-called "Epstein Files." Unlike mainstream social media platforms, Truth Social was designed as a haven for Trump and his supporters, where engagement overwhelmingly leans positive. The internal rift appears to stem from growing frustration over unfulfilled promises related to the Epstein case. Trump and several of his allies had long suggested that secret documents, including a so-called "client list," would be released under his administration. Bondi had previously claimed to possess such a list. But last week, the Justice Department announced that no list exists and reaffirmed that Epstein acted alone, dying by suicide in jail in 2019. The anticlimactic conclusion and the administration's refusal to release further files sparked fury from parts of Trump's base, especially activists and influencers who had built expectations around broader revelations. At the Turning Point USA Student Action Summit in Tampa this weekend, chants calling for Bondi's resignation could be heard. Trump's post defending her appeared to be a direct response to that dissent, but it only fueled it further. A user called Mother Rosie wrote: "This statement breaks my heart, Mr. President. I have four daughters, and live in Texas, where families lost little children. I can't even begin to comprehend the flipped narrative that 'it was so long ago' 'why are we still talking about this' and 'nobody should care.' These victims were some ones daughters, sisters, nieces, granddaughter. Someone's child. Please reconsider, sir. I voted for everything you are doing! Accountability was not something negotiable." Another woman, Crissy, who can be seen wearing a Trump-supporting beanie in her profile picture, said: "We want the ELITE PEDOS exposed! You promised us that. Pam promised us that. Kash promised us that. Now it's OUR fault bc we want that promise fulfilled and call Pam out every time she lies? What else has she lied to us about?" A third user, Dewayne Sykes, said: "This is going to cost you so many supporters. I being one of them." There will still some people speaking out in support of Trump in the comments, including from Navy veteran known as Robby F, who said: "We all want to know. But President Trump only has the evidence that these criminals left for him to find. If he gets his hands on anything that's useful, we will know." The data comes from an open-source GitHub repository which scrapes and stores all of Trump's Truth Social posts along with public metrics including reply count, like count, and re-truths. Using this dataset—which includes over 1,000 posts since 2022—Newsweek applied a filter to identify any posts where the number of replies exceeded both likes and shares. Only one post met that condition: the July 12, 2025 post defending Pam Bondi. Other posts in the archive occasionally drew large reply volumes, but in every case until now, likes or re-truths outnumbered them. This post represents the first—and so far only—time Trump was publicly rebuked by more of his own followers than supported him. FBI Director Kash Patel wrote on X on Saturday afternoon: "The conspiracy theories just aren't true, never have been. It's an honor to serve the President of the United States @realDonaldTrump—and I'll continue to do so for as long as he calls on me." Far-right political activist Laura Loomer on Saturday wrote on X: "President Trump says he thinks Blondi [sic] is 'doing a Fantastic job' as AG in a post he posted on Truth Social today...." Charlie Kirk, conservative founder and president of Turning Point USA, wrote on X: "President Trump on the Epstein Files, says he supports Pam Bondi at AG, the files are untrustworthy and created by Comey and Brennan. He wants his Justice Department focused on the voter fraud, the rigged election, ActBlue, and arresting thugs and criminals." While Trump used his Truth Social post to try shift focus away from the Epstein controversy, his followers seem unconvinced. The administration now faces the challenge of reuniting a fractured base ahead of the 2026 midterms elections. Related Articles India Accuses Pakistan of 'Violations,' After Trump Announced CeasefireTulsi Gabbard Outlines Four Key Priorities if ConfirmedTrudeau's Tariff Response: What Is IncludedFox News' Tucker Carlson Admits Trump Is A 'Full-Blown BS Artist' and 'Compulsive Self-Promoter' 2025 NEWSWEEK DIGITAL LLC.